Abstract:683 Background: Alternative splicing events can represent driver aberrations in cancer the same way as mutations, copy number changes, and gene fusions. We previously identified TP63 isoforms that were associated with prognosis in patients with bladder cancer and other tumor types. However, little is known about how isoform expression heterogeneity in other genes contributes to outcomes in bladder cancer. We hypothesized that expression of alternative isoforms in bladder cancer would be associated with clinical outcomes in a manner distinct from previously seen gene level associations. Methods: To examine this, we developed a high-throughput approach to identify and characterize prognostic gene isoforms that are associated with worse prognosis using RNA-sequencing data from The Cancer Genome Atlas (TCGA) bladder cancer cohort (BLCA). To identify gene isoforms that associate with bladder cancer outcomes, we aligned patient reads using HISAT2 and quantified expression for 69,272 isoforms using the Refseq isoform definitions from NCBI and the Stringtie algorithm. We filtered our quantifications to isoforms that belong to a gene with two or more isoforms, and those that had >0.1 Log2 TPM expression. The remaining 42,798 isoforms were tested for association with overall survival using cox regression and based on the following criteria: an isoform had to have a Hazard Ratio greater than 1 with a p-value < 0.05, an FDR adjusted p-value < 0.2 for a log-rank survival statistic using 3 quantile expression thresholds (25, 50 and 75 th ), and no significant gene-level association with disease prognosis. We validated our quantifications by confirming read coverage at the unique splice junctions for each isoform and by RT-PCR. We then performed differential expression and pathway enrichment analyses for tumors with or without expression of each pathogenic isoform. Results: 34 individual isoforms (from 30 genes) fit the criteria for association with survival. Several isoforms identified by our screen, such as FLNB, AXL, and COL6A3 isoforms, were previously shown to be associated with cancer outcomes in other tumor types. Expression of 7 isoforms were confirmed in human bladder cancer (2 isoforms of COL6A1, APLP2, TIAL1, and 1 isoform of FLNB) using RT-PCR. Expression of 21 of these prognostic isoforms were enriched in the aggressive basal squamous molecular subtype. Pathway analysis of TCGA BLCA tumors expressing these isoforms revealed enrichment of gene pathways associated with invasive cancer phenotypes, such as epithelial to mesenchymal transition and MYC targets. Conclusions: Specific isoforms are significantly associated with bladder cancer patient survival and suggest that splicing events in certain genes may act as driver aberrations in bladder cancer. Further work will need to be done to establish the regulatory mechanisms as well as how these isoforms contribute to cancer progression.

Landscape of transcript isoforms in single T cells infiltrating in non-small-cell lung cancer

Interrogations of single-cell RNA splicing landscapes with SCASL define new cell identities with physiological relevance

Single-cell differential splicing analysis reveals high heterogeneity of liver tumor-infiltrating T cells

Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing

Spatial Isoforms Reveal the Mechanisms of Metastasis.

An isoform-resolution transcriptomic atlas of colorectal cancer from long-read single-cell sequencing

A comparison of alternative mRNA splicing in the CD4 and CD8 T cell lineages

Single-cell RNA Cap and Tail Sequencing (Scrcat-Seq) Reveals Subtype-Specific Isoforms Differing in Transcript Demarcation

RNA Splicing Junction Landscape Reveals Abundant Tumor-Specific Transcripts in Human Cancer

Single-cell RNA-Seq reveals the link between CD45 isoforms and tumor-infiltrating T cells heterogeneity in liver cancer

Abstract 4356: An isoform-resolution transcriptomic atlas of colorectal cancer from long-read single-cell sequencing

Single-cell RNA Sequencing Analysis Revealed Cellular and Molecular Immune Profiles in Lung Squamous Cell Carcinoma

Single-cell Long Non-coding RNA Landscape of T Cells in Human Cancer Immunity

Single-Cell Transcriptomics of Immune Cells Reveal Diversity and Exhaustion Signatures in Non-Small-Cell Lung Cancer

Identification and characterization of prognostic isoforms associated with bladder cancer outcomes.

IsoCell: an Approach to Enhance Single Cell Clustering by Integrating Isoform-level Expression Through Orthogonal Projection

Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing

LAFITE Reveals the Complexity of Transcript Isoforms in Subcellular Fractions.

Single-molecule, full-length transcript isoform sequencing reveals disease-associated RNA isoforms in cardiomyocytes

Integrated Analysis of Differential Expression and Alternative Splicing of Non-Small Cell Lung Cancer Based on RNA Sequencing

Pan-cancer survey of lncRNA rewiring and functional alternation in tumor-infiltrating T cell by scLNC